Arbutus Biopharma (ABUS) Q2 2021 Earnings Report

1,286 Followers

ABUS Q2 2021 EPS Results

Actual EPS: -$0.23
Consensus EPS: -$0.23
Beat/Miss: Missed by -$0.01
One Year Ago EPS: -$0.25

ABUS Q2 2021 Revenue Results

Actual Revenue: $2.33M
Expected Revenue: $2.12M
Beat/Miss: Beat by +$211.00K
YoY Revenue Growth: +53.83%

Earnings Announcement Details

Quarter: Q2 2021
Date: 08/05/2021
Time: Before Open
Conference Call: Thursday, August 5, 2021

ABUS Upcoming Earnings

Arbutus Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

ABUS Earnings History

ABUS earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 11, 2026	2026 (Q3)	-0.02-	-0.04	―	―
Aug 12, 2026	2026 (Q2)	-0.02-0.03	0.01	-400.00% (-0.04)
May 13, 2026	2026 (Q1)	-0.030.87	-0.13	769.23% (+1.00)
Mar 23, 2026	2025 (Q4)	-0.04-0.01	-0.07	85.71% (+0.06)
Nov 13, 2025	2025 (Q3)	-0.03-0.04	-0.1	60.00% (+0.06)
Aug 06, 2025	2025 (Q2)	-0.050.01	-0.11	109.09% (+0.12)
May 14, 2025	2025 (Q1)	-0.10-0.13	-0.1	-30.00% (-0.03)
Mar 27, 2025	2024 (Q4)	-0.08-0.07	-0.12	41.67% (+0.05)
Nov 06, 2024	2024 (Q3)	-0.09-0.10	-0.12	16.67% (+0.02)
Aug 01, 2024	2024 (Q2)	-0.10-0.11	-0.1	-10.00% (-0.01)
May 02, 2024	2024 (Q1)	-0.11-0.10	-0.1	0.00% (+0.00)
Feb 29, 2024	2023 (Q4)	-0.12-0.12	-0.13	7.69% (+0.01)
Nov 07, 2023	2023 (Q3)	-0.11-0.12	-0.12	0.00% (+0.00)
Aug 03, 2023	2023 (Q2)	-0.11-0.10	-0.1	0.00% (+0.00)
May 04, 2023	2023 (Q1)	-0.14-0.10	-0.11	9.09% (+0.01)
Mar 02, 2023	2022 (Q4)	-0.13-0.13	-0.15	13.33% (+0.02)
Nov 09, 2022	2022 (Q3)	-0.13-0.12	-0.24	50.00% (+0.12)
Aug 04, 2022	2022 (Q2)	-0.12-0.10	-0.23	56.52% (+0.13)
May 05, 2022	2022 (Q1)	-0.16-0.11	-0.21	47.62% (+0.10)
Mar 03, 2022	2021 (Q4)	-0.19-0.15	-0.23	34.78% (+0.08)
Nov 04, 2021	2021 (Q3)	-0.24-0.24	-0.27	11.11% (+0.03)
Aug 05, 2021	2021 (Q2)	-0.23-0.23	-0.25	8.00% (+0.02)
May 05, 2021	2021 (Q1)	―-0.21	-0.25	16.00% (+0.04)
Mar 04, 2021	2020 (Q4)	―-0.23	-0.46	50.00% (+0.23)
Nov 05, 2020	2020 (Q3)	―-0.27	-1.5	82.00% (+1.23)
Aug 07, 2020	2020 (Q2)	―-0.25	-0.46	45.65% (+0.21)
May 11, 2020	2020 (Q1)	―-0.25	-0.47	46.81% (+0.22)
Mar 05, 2020	2019 (Q4)	―-0.46	-0.37	-24.32% (-0.09)
Nov 06, 2019	2019 (Q3)	―-1.50	-0.49	-206.12% (-1.01)
Aug 05, 2019	2019 (Q2)	―-0.46	0.01	-4700.00% (-0.47)
May 06, 2019	2019 (Q1)	―-0.47	-0.36	-30.56% (-0.11)
Mar 07, 2019	2018 (Q4)	―-0.37	-0.68	45.59% (+0.31)
Nov 07, 2018	2018 (Q3)	―-0.49	-0.21	-133.33% (-0.28)
Aug 02, 2018	2018 (Q2)	―0.01	-0.33	103.03% (+0.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Arbutus Biopharma earnings date